Furthermore, a novel protein (circMAPK14‐175aa), encoded by circMAPK14, exhibited tumour‐suppressive effects and competed with upstream kinase MKK6 to facilitate ubiquitin‐mediated degradation of FOXC1 and block CRC development. The gene discussed is MAP2K6; the disease is neoplasm.